MedTrace Logo

Pazufloxacin Mesilate Ear Drops in Patients With Chronic Suppurative Otitis Media

NCT03675841 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2018-09-26

No results posted yet for this study

Summary

Objective To observe the safety and tolerability of Pazufloxacin Mesylate Ear Drops of different concentrations in patients with simple chronic suppurative otitis media.

Conditions

  • Chronic Suppurative Otitis Media

Interventions

DRUG

Pazufloxacin Mesilate ear drops

Pazufloxacin Mesilate ear drops of 0.1%，0.3%，0.5%

Sponsors & Collaborators

  • Lee's Pharmaceutical Limited

    lead INDUSTRY

Principal Investigators

  • lei chen, PHD · Jiangsu Province People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-29
Primary Completion
2019-01-30
Completion
2019-06-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03675841 on ClinicalTrials.gov